-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$14.001672.15% Upside
ProPhase Labs, Inc. Frequently Asked Questions
-
What analysts cover ProPhase Labs, Inc.?
ProPhase Labs, Inc. has been rated by research analysts at H.C. Wainwright in the past 90 days.